Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000012794 | SCV000697265 | pathogenic | Propionic acidemia | 2017-03-02 | criteria provided, single submitter | clinical testing | Variant summary: The PCCB c.1173dupT (p.Val392Cysfs) variant results in a premature termination codon, predicted to cause a truncated or absent PCCB protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g.p.Gly407fs). One in silico tool predicts a damaging outcome for this variant. This variant is one of the most common pathogenic variant in Spanish patients with propionic acidemia and is absent in 121400 control chromosomes. Functional studies showed that the protein levels and PCC activity were extremely low in patients carrying this variant. Taken together, this variant is classified as pathogenic. |
Invitae | RCV000012794 | SCV000961041 | pathogenic | Propionic acidemia | 2023-12-31 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val392Cysfs*2) in the PCCB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCCB are known to be pathogenic (PMID: 15464417). This variant is present in population databases (rs753064211, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with propionic acidemia (PMID: 9452096, 9683601, 20549364). ClinVar contains an entry for this variant (Variation ID: 12014). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001576958 | SCV001804251 | pathogenic | not provided | 2022-10-13 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 9683601, 10780784, 9452096, 20549364, 25865301, 32778825) |
Fulgent Genetics, |
RCV000012794 | SCV002812012 | pathogenic | Propionic acidemia | 2022-03-14 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000012794 | SCV004205195 | pathogenic | Propionic acidemia | 2023-09-09 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000012794 | SCV000033034 | pathogenic | Propionic acidemia | 1998-08-01 | no assertion criteria provided | literature only | |
Counsyl | RCV000012794 | SCV001132453 | pathogenic | Propionic acidemia | 2017-06-30 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000012794 | SCV001454525 | pathogenic | Propionic acidemia | 2020-09-16 | no assertion criteria provided | clinical testing |